Literature DB >> 17931355

Expression of mutant ubiquitin (UBB+1) and p62 in myotilinopathies and desminopathies.

M Olivé1, F W van Leeuwen, A Janué, D Moreno, B Torrejón-Escribano, I Ferrer.   

Abstract

Protein aggregates in muscle cells are the morphological hallmark of myofibrillar myopathies, including myotilinopathies and desminopathies. The aim of the present study is to analyse the expression of mutant ubiquitin (UBB+1), an aberrant form of ubiquitin which accumulates in certain disorders characterized by intracellular aggregates of proteins, and p62, a multimeric signal protein which plays an active role in aggregate formation, in muscle biopsies from patients suffering from myotilinopathy and desminopathy in order to gain understanding of the mechanisms leading to protein aggregation in these disorders. Single immunohistochemistry, and single- and double-labelling immunofluorescence and confocal microscopy for UBB+1 and p62, has been performed in muscle biopsies from patients suffering from myotilinopathy and desminopathy. Strong UBB+1 immunoreactivity, colocalizing with myotilin aggregates, was found in muscle fibres in myotilinopathies. UBB+1 accumulation, colocalizing with desmin aggregates, also occurs in desminopathies. In addition, strong p62 immunoreactivity colocalizing with myotilin aggregates was observed in myotilinopathies. Similarly, p62 immunoreactivity colocalizing with desmin aggregates was found in desminopathies. The present findings suggest that accumulation of protein aggregates in myotilinopathies and in desminopathies may be related with UBB+1/abnormal protein complexes which are resistant to proteasome degradation. Furthermore, these observations suggest a relationship between the presence of p62 and the formation of inclusions in different subtypes of myofibrillar myopathies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17931355     DOI: 10.1111/j.1365-2990.2007.00864.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  21 in total

1.  DNAJB2 expression in normal and diseased human and mouse skeletal muscle.

Authors:  Kristl G Claeys; Magdalena Sozanska; Jean-Jacques Martin; Emmanuelle Lacene; Ludivine Vignaud; Daniel Stockholm; Pascal Laforêt; Bruno Eymard; Antoine Kichler; Daniel Scherman; Thomas Voit; David Israeli
Journal:  Am J Pathol       Date:  2010-04-15       Impact factor: 4.307

2.  Deficiencies in tRNA synthetase editing activity cause cardioproteinopathy.

Authors:  Ye Liu; Jakob S Satz; My-Nuong Vo; Leslie A Nangle; Paul Schimmel; Susan L Ackerman
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-24       Impact factor: 11.205

Review 3.  Myofibrillar myopathies.

Authors:  Duygu Selcen
Journal:  Neuromuscul Disord       Date:  2011-01-20       Impact factor: 4.296

4.  Characterizing polyubiquitinated forms of the neurodegenerative ubiquitin mutant UBB+1.

Authors:  Michal Chojnacki; Daoning Zhang; Monika Talarowska; Piotr Gałecki; Janusz Szemraj; David Fushman; Mark A Nakasone
Journal:  FEBS Lett       Date:  2016-11-22       Impact factor: 4.124

5.  Doxycycline attenuates protein aggregation in cardiomyocytes and improves survival of a mouse model of cardiac proteinopathy.

Authors:  Hanqiao Zheng; Mingxin Tang; Qingwen Zheng; Asangi R K Kumarapeli; Kathleen M Horak; Zongwen Tian; Xuejun Wang
Journal:  J Am Coll Cardiol       Date:  2010-10-19       Impact factor: 24.094

6.  Abnormal accumulation of desmin in gastrocnemius myofibers of patients with peripheral artery disease: associations with altered myofiber morphology and density, mitochondrial dysfunction and impaired limb function.

Authors:  Panagiotis Koutakis; Dimitrios Miserlis; Sara A Myers; Julian Kyung-Soo Kim; Zhen Zhu; Evlampia Papoutsi; Stanley A Swanson; Gleb Haynatzki; Duy M Ha; Lauren A Carpenter; Rodney D McComb; Jason M Johanning; George P Casale; Iraklis I Pipinos
Journal:  J Histochem Cytochem       Date:  2015-01-09       Impact factor: 2.479

7.  Target genes of neuron-restrictive silencer factor are abnormally up-regulated in human myotilinopathy.

Authors:  Marta Barrachina; Jesús Moreno; Salvador Juvés; Dolores Moreno; Montse Olivé; Isidre Ferrer
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

8.  Intermediate filament diseases: desminopathy.

Authors:  Lev G Goldfarb; Montse Olivé; Patrick Vicart; Hans H Goebel
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

9.  Gender dimorphic formation of mouse Mallory-Denk bodies and the role of xenobiotic metabolism and oxidative stress.

Authors:  Shinichiro Hanada; Natasha T Snider; Elizabeth M Brunt; Paul F Hollenberg; M Bishr Omary
Journal:  Gastroenterology       Date:  2010-01-11       Impact factor: 22.682

10.  Pathophysiology of protein aggregation and extended phenotyping in filaminopathy.

Authors:  Rudolf A Kley; Piraye Serdaroglu-Oflazer; Yvonne Leber; Zagaa Odgerel; Peter F M van der Ven; Montse Olivé; Isidro Ferrer; Adekunle Onipe; Mariya Mihaylov; Juan M Bilbao; Hee S Lee; Jörg Höhfeld; Kristina Djinović-Carugo; Kester Kong; Martin Tegenthoff; Sören A Peters; Werner Stenzel; Matthias Vorgerd; Lev G Goldfarb; Dieter O Fürst
Journal:  Brain       Date:  2012-09       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.